Universal HealthWatch in $12 million medical technology deal with Russia
This article was originally published in Clinica
Executive Summary
Under a one-year $12 million contract, privately-owned Universal HealthWatch (US) will provide medical technology to Russia. Programmes include provision of diagnostics for communicable diseases; the transfer of manufacturing technology for diagnostics to Russia over five years; an evaluation and exchange of technology between the two countries; conducting seminars on surgical procedures; and consultancy services for GMP manufacture.